1. Home
  2. Sofosbuvir
  Subject:

Sofosbuvir   New Search

View on DBpedia    View on Wikipedia
Top related subjects:
RELATED SUBJECTS:
The publications listed also have these subjects
Ribavirin  9 times
Hepatitis C virus  9 times
Daclatasvir  8 times
Hepatitis C  7 times
Cirrhosis  7 times
NS5A  3 times
RNA  2 times
Liver transplantation  2 times
Japan  2 times
Interferon  2 times
India  2 times
Carcinoma  2 times
Viral load  1 time
Thrombocytopenia  1 time
Tacrolimus  1 time
Substance dependence  1 time
Serine  1 time
Random effects model  1 time
RNA virus  1 time
Pulmonary alveolus  1 time
PubMed  1 time
Protein  1 time
Protease  1 time
Polymerase  1 time
Pneumonia  1 time
Pleural effusion  1 time
Odds ratio  1 time
Metabolism  1 time
Meta-analysis  1 time
Logistic regression  1 time
Liver biopsy  1 time
Lipid  1 time
Linear regression  1 time
Kidney transplantation  1 time
Interstitial lung disease  1 time
Incremental cost-effectiveness ratio  1 time
Human rights  1 time
Hemodialysis  1 time
Helicase  1 time
Genotype  1 time
Genetic code  1 time
Enzyme inhibitor  1 time
Embase  1 time
Disease  1 time
Dialysis  1 time
Clinical trial  1 time
Ciclosporin  1 time
Cholesterol  1 time
Blood transfusion  1 time
Bleeding  1 time
Alanine transaminase  1 time

Publications tagged with this subject: 14

Note: Top 50 publications shown only. Open an item panel to view more info (open all)


1. Treatment with sofosbuvir and ledipasvir without ribavirin for 12 weeks is highly effective for recurrent hepatitis C virus genotype 1b infection after living donor liver transplantation: a Japanese multicenter experience

2. Three patients treated with sofosbuvir plus ledipasvir for recurrent hepatitis C after liver transplantation

3. Detection of a genetic footprint of the sofosbuvir resistance-associated substitution S282T after HCV treatment failure

4. Efficacy and safety of ledipasvir/sofosbuvir with ribavirin in chronic hepatitis C patients who failed daclatasvir/asunaprevir therapy: pilot study

5. Chemical genetics-based development of small molecules targeting hepatitis C virus

6. A fixed-dose combination of ledipasvir and sofosbuvir ± ribavirin for treatment of hepatitis C infection: a systematic review and meta-analysis

7. Treatment Discontinuation, Adherence, and Real-World Effectiveness Among Patients Treated with Ledipasvir/Sofosbuvir in the United States

8. Treatment of chronic genotype-3 hepatitis C virus infection using direct-acting antiviral agents: An Indian experience

9. Health-Related Quality of Life in Chronic HCV-Infected Patients Switching to Pegylated-Interferon-Free Regimens (ANRS CO20 CUPIC Cohort Study and SIRIUS Trial)

10. Efficacy and safety of sofosbuvir-based regimens in chronic hepatitis C patients on dialysis

11. Hepatitis C Virus-Genotype 3: Update on Current and Emergent Therapeutic Interventions

12. Selling pharmaceuticals ethically in resource-limited settings: the case of Sofosbuvir

13. Estimating the cost-effectiveness of daclatasvir + sofosbuvir versus sofosbuvir + ribavirin for patients with genotype 3 hepatitis C virus

14. Retreatment with sofosbuvir, ledipasvir, and add-on ribavirin for patients who failed daclatasvir and asunaprevir combination therapy


Questions?

Drop us a message.